Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
ConditionInternal Hemorrhoid
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorMayo Clinic
About this trial
This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.
Eligibility criteria
Qualifiers
Grade II or III hemorrhoidal disease as determined by a board-certified colorectal surgeon.
Persistent or recurrent symptoms following hygiene and dietary measures or medication.
Bleeding predominant ± pain symptoms.
Undergoing planned rectal artery embolization (RAE) per standard clinical care.
Disqualifiers
Prior hemorrhoid surgery.
Grade IV hemorrhoidal disease.
Acute hemorrhoid complications.
Chronic anal or perianal fissures.
Trial design
Treatments tested in this trial
- Rectal Artery Embolization
Treatment groups
No treatment groups listed
Sponsors and collaborators
Mayo Clinic
Lead sponsor
Terumo Corporation
Collaborator
Source ClinicalTrials.gov